HM
Hemostemix Inc
HMTXF · OTC
$0.05 -1.33% (-$0.00)
1M +7.42%
Market Cap $14.4M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.03
43.7% downside
Current Price
$0.053
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HMTXF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A PEG N/A
P/E N/A
P/B N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 336.74%
ROA 1,758.21%
Debt
0 /100
High Int. coverage -11.72x
Current ratio 0.13x
Debt/Assets N/A
Stability
62 /100
Moderate Profitable years 0
Beta 0.61x
EPS volatility 33.77%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HMTXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Thomas A. Smeenk
Employees
488
Headquarters
Calgary
Upcoming events
27 NOV
Earnings
Upcoming earnings report